Michelle Callegan to Microbial Sensitivity Tests
This is a "connection" page, showing publications Michelle Callegan has written about Microbial Sensitivity Tests.
Connection Strength
0.240
-
Toward improving therapeutic regimens for Bacillus endophthalmitis. Invest Ophthalmol Vis Sci. 2008 Apr; 49(4):1480-7.
Score: 0.073
-
Virulence factor profiles and antimicrobial susceptibilities of ocular bacillus isolates. Curr Eye Res. 2006 Sep; 31(9):693-702.
Score: 0.065
-
Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther. 2003 Sep-Oct; 20(5):246-52.
Score: 0.053
-
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 1992 Oct; 33(11):3017-23.
Score: 0.025
-
Clonal associations among Staphylococcus aureus isolates from various sites of infection. Infect Immun. 2001 Jan; 69(1):345-52.
Score: 0.011
-
Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993 May; 12(5):469-73.
Score: 0.006
-
Bioassays for quantitating ciprofloxacin and tobramycin in aqueous humor. J Ocul Pharmacol. 1993; 9(4):311-20.
Score: 0.006